Gallant
Developer of a pet health technology platform designed to deliver regenerative stem cell therapies for improved veterinary care. The company's platform offers standardized stem cell banking, allogenei...
Valuation
$72M
Market implied
Share Price
N/A
Total Raised
$42.5M
Last Round
N/A